Clinical Commissioning Policy: Selexipag for treating pulmonary arterial hypertension (all ages)

Document first published:: 6 July 2018
Page updated:: 6 July 2018
Topic:: Commissioning, Specialised commissioning
Publication type:: Policy or strategy

This policy document outlines the arrangements for funding of treatment for pulmonary arterial hypertension.

Document

Clinical Commissioning Policy: Selexipag for treating pulmonary arterial hypertension (all ages)

Clinical Commissioning Policy: Selexipag for treating pulmonary arterial hypertension (all ages)

19 pages